Mutations in the Extracellular Domain Cause RET Loss of Function by a Dominant Negative Mechanism

REFERENCES

• Angrist, M., S. Bolk, B. Thiel, E. G. Puffemberger, R. M. W. Hofstra, C. H. C. M. Buys, D. T. Cass, and A. Chakravarti 1995. Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Hum. Mol. Genet. 4: 821–830.
   PubMed Web of Science ®Google Scholar
• Asai, N., T. Iwashita, M. Matsuyama, and M. Takahashi 1995. Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol. Cell. Biol. 15: 1613–1619.
   PubMed Web of Science ®Google Scholar
• Avantaggiato, V., N. A. Dathan, M. Grieco, N. Fabien, D. Lazzaro, A. Fusco, A. Simeone, and M. Santoro 1994. Developmental expression of the RET proto-oncogene. Cell Growth Differ. 5: 305–311.
   PubMedGoogle Scholar
• Bongarzone, I., N. Monzini, M. G. Borrello, C. Carcano, G. Ferraresi, E. Arighi, P. Mondellini, G. Della Porta, and M. A. Pierotti 1993. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RIα of cyclic AMP-dependent protein kinase A. Mol. Cell. Biol. 13: 358–366.
   PubMedGoogle Scholar
• Buj Bello, A., J. Adu, L. G. Pinon, A. Horton, J. Thompson, A. Rosenthal, M. Chinchetru, V. L. Buchman, and A. M. Davies 1997. Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase. Nature 387: 721–724.
   PubMedGoogle Scholar
• Carlomagno, F., G. De Vita, M. T. Berlingieri, V. de Franciscis, R. M. Melillo, V. Colantuoni, M. H. Kraus, P. P. Di Fiore, A. Fusco, and M. Santoro 1996. Molecular heterogeneity of RET loss of function in Hirschsprung’s disease. EMBO J. 15: 2717–2725.
   PubMed Web of Science ®Google Scholar
• Collesi, C., M. Santoro, G. Gaudino, and P. Comoglio 1996. A splicing variant of the RON transcript induces contitutive tyrosine kinase activity and an invasive phenotype. Mol. Cell. Biol. 16: 5518–5526.
   PubMed Web of Science ®Google Scholar
• Cosma, M. P., L. Panariello, L. Quadro, N. A. Datan, O. Fattoruso, and V. Colantuoni 1996. A mutation in the RET proto-oncogene in Hirschsprung’s disease affects the tyrosine kinase activity associated with multiple endocrine neoplasia type 2A and 2B. Biochem. J. 314: 397–400.
   PubMedGoogle Scholar
• Coulier, F., R. Kumar, M. Ernst, R. Klein, D. Martin-Zanca, and M. Barbacid 1990. Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain. Mol. Cell. Biol. 10: 4202–4210.
   PubMedGoogle Scholar
• Donis-Keller, H., S. Dou, D. Chi, K. M. Carlson, K. Toshima, T. C. Lairmore, J. R. Howe, P. Goodfellow, and S. A. Wells 1993. Mutations in the RET proto-oncogene are associated with MEN2A and FMTC. Hum. Mol. Genet. 2: 851–856.
   PubMed Web of Science ®Google Scholar
• Durbec, P., C. V. Marcos Gutierrez, C. Kilkenny, M. Grigoriou, K. Wartiowaara, P. Suvanto, D. Smith, B. Ponder, F. Costantini, M. Saarma, H. Sariola, and V. Pachnis 1996. GDNF signalling through the Ret receptor tyrosine kinase. Nature 381: 789–793.
   PubMed Web of Science ®Google Scholar
• Edery, P., S. Lyonnet, L. M. Mulligan, A. Pelet, E. Dow, L. Abel, S. Holder, C. Nihoul, B. A. J. Ponder, and A. Munnich 1994. Mutations of the RET proto-oncogene in Hirschsprung’s disease. Nature 367: 378–380.
   PubMed Web of Science ®Google Scholar
• Eng, C., and L. M. Mulligan 1997. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease. Hum. Mutat. 9: 97–109.
   PubMed Web of Science ®Google Scholar
• Graham, F. L., and A. J. van der Eb 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456–467.
   PubMed Web of Science ®Google Scholar
• Hofstra, R. M. W., R. M. Landsvater, I. Ceccherini, R. P. Stulp, T. Stelwagen, Y. Luo, B. Pasini, J. W. M. Hoppener, H. K. Ploos van Amstel, G. Romeo, C. J. M. Lips, and C. H. C. M. Buys 1994. A mutation in the RET protooncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367: 375–376.
   PubMed Web of Science ®Google Scholar
• Ikeda, I., Y. Ishizaka, T. Tahira, T. Suzuki, M. Onda, T. Sugimura, and M. Nagao 1990. Specific expression of the RET proto-oncogene in human neuroblastoma cell lines. Oncogene 5: 1291–1296.
   PubMedGoogle Scholar
• Iwashita, T., H. Murakami, N. Asai, and M. Takahashi 1996. Mechanism of Ret dysfunction by Hirschsprung mutations affecting its extracellular domain. Hum. Mol. Genet. 5: 1577–1580.
   PubMedGoogle Scholar
• Jing, S., D. Wen, Y. Yu, P. L. Holst, Y. Luo, M. Fang, R. Tamir, L. Antonio, Z. Hu, R. Cupples, J. C. Louis, S. Hu, B. W. Altrock, and G. M. Fox 1996. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85: 1113–1124.
   PubMed Web of Science ®Google Scholar
• Klein, R. D., D. Sherman, W. H. Ho, D. Stone, G. L. Bennett, B. Moffat, R. Vandlen, L. Simmons, Q. Gu, J. A. Hongo, B. Devaux, K. Poulsen, M. Armanini, C. Nozaki, N. Asai, A. Goddard, H. Phillips, C. E. Henderson, M. Takahashi, and A. Rosenthal 1997. A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature 387: 717–721.
   PubMedGoogle Scholar
• Luo, Y., I. Ceccherini, B. Pasini, I. Matera, M. P. Bicocchi, V. Barone, R. Bocciardi, H. Kaariaiainen, D. Weber, M. Devoto, and G. Romeo 1993. Close linkage with the RET proto-oncogene and boundaries of deletion mutants in autosomal dominant Hischsprung disease. Hum. Mol. Genet. 11: 1803–1808.
   Google Scholar
• Martucciello, G., M. P. Bicocchi, P. Dodero, M. Lerone, M. S. Cirillo, A. Puliti, G. Gimelli, G. Romeo, and V. Jasonni 1992. Total colonic aganglionosis associated with interstitial deletion of the long arm of chromosome 10. Pediatr. Surg. Int. 7: 308–310.
   Google Scholar
• Mulligan, L. M., J. B. Kwok, C. S. Healey, M. J. Elsdon, C. Eng, E. Gardner, D. R. Love, S. E. Mole, and J. K. Moore 1993. Germline mutations of the RET protooncogene in multiple endocrine neoplasia type 2A families. Nature 363: 458–460.
   PubMed Web of Science ®Google Scholar
• Nakamura, T., Y. Ishizaka, M. Nagao, M. Hara, and T. Ishikawa 1994. Expression of the ret proto-oncogene product in human normal and neoplastic tissues of neural crest origin. J. Pathol. 172: 255–260.
   PubMed Web of Science ®Google Scholar
• Pachnis, V., B. Mankoo, and F. Costantini 1993. Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119: 1005–1017.
   PubMed Web of Science ®Google Scholar
• Pasini, B., M. G. Borrello, A. Greco, I. Bongarzone, Y. Luo, P. Mondellini, L. Alberti, C. Miranda, E. Arighi, R. Bocciardi, M. Seri, V. Barone, M. T. Radice, G. Romeo, and M. A. Pierotti 1995. Loss of function effect of RET mutations causing Hirschsprung disease. Nat. Genet. 10: 35–40.
   PubMed Web of Science ®Google Scholar
• Passarge, E. 1967. The genetics of Hirschsprung’s disease. N. Engl. J. Med. 276: 138–141.
   PubMed Web of Science ®Google Scholar
• Rodriguez, G. A., M. A. Naujokas, and M. Park 1991. Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing. Mol. Cell. Biol. 11: 2962–2970.
   PubMedGoogle Scholar
• Romeo, G., P. Ronchetto, Y. Luo, V. Barone, M. Seri, I. Ceccherini, B. Pasini, R. Bocciardi, M. Lerone, H. Kaariainen, and G. Martucciello 1994. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung’s disease. Nature 367: 377–378.
   PubMed Web of Science ®Google Scholar
• Sanchez, M. P., I. Silos Santiago, J. Frisen, B. He, S. A. Lira, and M. Barbacid 1996. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382: 70–73.
   PubMed Web of Science ®Google Scholar
• Santoro, M., R. Rosati, M. Grieco, M. T. Berlingieri, L. C. D’Amato, V. De Franciscis, and A. Fusco 1990. The RET proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene 5: 1595–1598.
   PubMed Web of Science ®Google Scholar
• Santoro, M., F. Carlomagno, A. Romano, D. P. Bottaro, N. A. Dathan, M. Grieco, A. Fusco, G. Vecchio, B. Matoskova, M. H. Kraus, and P. P. Di Fiore 1995. Germ-line mutations of MEN2A and MEN2B activate RET as a dominant transforming gene by different molecular mechanisms. Science 267: 381–383.
   PubMed Web of Science ®Google Scholar
• Schimke, R. N. 1984. Genetic aspects of multiple endocrine neoplasia. Annu. Rev. Med. 35: 25–31.
   PubMedGoogle Scholar
• Schuchardt, A., V. D’Agati, L. L. Blomberg, F. Costantini, and V. Pachnis 1994. The c-ret receptor tyrosine kinase gene is required for the development of the kidney and enteric nervous system. Nature 367: 380–383.
   PubMed Web of Science ®Google Scholar
• Songyang, Z., Carraway, K. L.III, M. J. Eck, S. C. Harrison, R. Feldman, M. Mohammadi, J. Schlessinger, S. R. Hubbard, D. P. Smith, C. Eng, M. J. Lorenzo, B. A. J. Ponder, B. J. Mayer, and L. C. Cantley 1995. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373: 536–539.
   PubMed Web of Science ®Google Scholar
• Takahashi, M., Y. Buma, T. Iwamoto, Y. Inaguma, H. Ikeda, and H. Hiai 1988. Cloning and expression of the ret protooncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 3: 571–578.
   PubMed Web of Science ®Google Scholar
• Takahashi, M., Y. Buma, and H. Hiai 1989. Isolation of the ret proto-oncogene cDNA with an amino-terminal signal sequence. Oncogene 4: 805–806.
   PubMed Web of Science ®Google Scholar
• Takahashi, M., N. Asai, T. Iwashita, T. Isomura, and K. Miyazaki 1993. Characterization of the RET proto-oncogene products expressed in mouse L cells. Oncogene 6: 297–301.
   Google Scholar
• Treanor, J., L. Goodman, F. de Sauvage, D. M. Stone, K. T. Poulsen, C. D. Beck, C. Gray, M. P. Armanini, R. A. Pollock, F. Hefti, H. S. Phillips, A. Goddard, M. W. Moore, A. Buj-Bello, A. M. Davies, N. Asai, M. Takahashi, R. Vandlen, C. E. Henderson, and A. Rosenthal 1996. Characterization of a multicomponent receptor for GDNF. Nature 382: 80–83.
   PubMed Web of Science ®Google Scholar
• Trupp, M., E. Arenas, M. Fainzilber, A. S. Nilsson, B. A. Sieber, M. Grigoriou, C. Kilkenny, E. S. Grueso, V. Pachnis, U. Arumae, H. Sariola, M. Saarma, and C. F. Ibanez 1996. Functional receptor for GDNF encoded by c-ret proto-oncogene. Nature 381: 785–789.
   PubMed Web of Science ®Google Scholar
• Worby, C. A., Q. C. Vega, Y. Zhao, H. H. J. Chao, A. F. Seasholtz, and J. E. Dixon 1996. Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase. J. Biol. Chem. 271: 23619–23622.
   PubMed Web of Science ®Google Scholar